Châtillon, France, October 18, 2024DBV Technologies to Participate in Upcoming ACAAI 2024 CongressDBV Technologies (Euronext: DBV – ISIN: ...

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that five abstracts have been accepted for e-Poster presentation at the 2024 Annual Sci ...

Full session details can be accessed on the ACAAI website. The poster will be available on the publications page of the Apogee website on October 24.

In anticipation of the 2024 ACAAI Annual Scientific Meeting, Ruchi Gupta, MD, highlights advances in food allergy and gastrointestinal disorder management. This year, Dr Gupta is particularly ...

HAE is a rare and potentially life-threatening genetic condition that involves recurrent attacks of severe swelling (angioedema) in various parts of the body, including the hands, feet, genitals ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

Dr Gupta previews the 2024 ACAAI Annual Scientific Meeting, where she is anticipating updates on the first FDA-approved biologic therapy for food allergies, along with other advancements in ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

Results will be presented at the 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in Boston, Massachusetts. New data at ACAAI demonstrate donidalorsen ...